PKCα also modulates the intestinal macrophage iron exporter Fpn, thereby aggravating iron deposition in diabetes and hemochromatosis, which can be effectively reversed by pharmacological inhibition [272]. This evidence concerns the gene PRKCA and diabetes mellitus.